MNMasaji Nishimura

Masaji Nishimura

*This is an algorithmically generated author record based on publicly available information.

Masaji Nishimura has a total of 136 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Optimal oxygenation in the intensive care unit: what recent trials do—and do not—tell us

    by Masaji Nishimura

    Oxygen therapy is one of the most widely used interventions in critical care. Numerous observational studies and randomized controlled trials (RCTs) have evaluated conservative versus liberal oxygenation strategies, yet their results remain inconsistent, a pattern commonly observed in large clinical trials across multiple fields. Recent advances in intensive care unit practices further complicate the interpretation of prior findings, highlighting the need for a clearer framework to interpret oxygenation targets. This narrative review summarizes major observational studies, RCTs, and meta-analyses evaluating oxygenation strategies in critically ill patients. We examine variation in study designs, target and achieved oxygenation levels, and evolving critical care practices. Physiological principles, including oxygen delivery, oxygen utilization, and the oxyhemoglobin dissociation curve, are applied to interpret current evidence and define clinically meaningful safety margins, while acknowledging the limitations of interpreting heterogeneous trial and meta-analytic results. Recent RCTs have found relatively small differences in oxygenation between study groups; both conservative and liberal oxygenation targets are generally within a safe physiological range. However, evidence from the LOCO2 trial indicates excessively low targets may be harmful, suggesting a safer lower limit of approximately peripheral oxygen saturation (SpO2) 92%–93%. Retrospective studies indicate acceptable outcomes with arterial oxygen partial pressure (PaO2) values up to approximately 120 mm Hg. Because the upper portion of the oxyhemoglobin dissociation curve is flat, SpO2 cannot reliably detect hyperoxemia. Rather than determining the superiority of conservative or liberal oxygenation strategies, current evidence supports defining a practical therapeutic window. For most critically ill patients, an SpO2 range of 92–97% likely represents a safe and clinically meaningful target.

  • Open Access

    Development and 2025 re-evaluation of a Japanese quality indicator set for adult intensive care: a modified RAND/UCLA Delphi study

    by Junji Kumasawa, Hiroshi Okamoto, Takaki Naito, Takehiko Asaga, Masayoshi Kimura, Toru Kotani, Yasuhiro Komatsu, Takeshi Suzuki, Tetsuya Takahashi, Tetsuhiro Takei, et al.

    Background: Quality indicators (QIs) support measurement and improvement of ICU care; however, until 2017 there was no comprehensive, evidence-based QI set tailored to frontline adult ICU practice in Japan. Because evidence and practice evolve, periodic updating is required. We developed a Japanese ICU QI set in 2017–2018 and conducted a formal re-evaluation in 2025 to confirm current validity and update the core set. Methods: We used a modified RAND/UCLA appropriateness method. First, an initial list of candidate QIs was generated through a systematic literature review and major clinical guidelines. Next, a multidisciplinary panel of 14 Japanese experts (including intensivists, a nurse, a physiotherapist, and a clinical engineer) rated the appropriateness of these indicators using a nine-point Likert scale (Round 1). Following Round 1, a face-to-face consensus meeting was held to discuss, refine, add, or delete indicators based on scientific evidence, clinical importance, and feasibility, followed by Round 2 to finalize the 2018 consensus set. In 2025 (Round 3), the panel re-rated all indicators from the 2018 set using the same rating and classification framework and also rated newly proposed indicators reflecting contemporary practice. Results: The systematic review yielded 44 initial candidate QIs. After the two-round rating process and the expert panel meeting, a 2018 consensus set of 38 QIs was established (13 structure indicators, 10 process indicators, and 15 outcome indicators). In Round 3 (2025), 37 indicators remained Appropriate, whereas one indicator was reclassified as Uncertain and was not retained in the updated core set. One newly proposed indicator was rated Appropriate and added, resulting in an updated 2025 core set of 38 indicators. All selected indicators were deemed appropriate and relevant for the Japanese ICU setting by the expert panel. Conclusions: Using a rigorous modified RAND/UCLA appropriateness method and a 2025 re-evaluation, we developed and updated a feasible, contextually adapted Japanese ICU QI set. The updated core set, with operational definitions and specified data sources, provides a foundation for national benchmarking and continuous quality improvement in Japanese ICUs. 330 words.


  • Open Access

    Upper limb muscle atrophy associated with in-hospital mortality and physical function impairments in mechanically ventilated critically ill adults: a two-center prospective observational study

    by Nobuto Nakanishi, Jun Oto, Rie Tsutsumi, Yusuke Akimoto, Yuki Nakano, Masaji Nishimura

    Background: Lower limb muscle atrophy is often observed in critically ill patients. Although upper limb muscles can undergo atrophy, it remains unclear how this atrophy is associated with clinical outcomes. We hypothesized that this atrophy is associated with mortality and impairments in physical function.Methods: In this two-center prospective observational study, we included adult patients who were expected to require mechanical ventilation for > 48 h and remain in the intensive care unit (ICU) for > 5 days. We used ultrasound to evaluate the cross-sectional area of the biceps brachii on days 1, 3, 5, and 7 and upon ICU discharge along with assessment of physical functions. The primary outcome was the relationship between muscle atrophy ratio and in-hospital mortality on each measurement day, which was assessed using multivariate analysis. The secondary outcomes were the relationships between upper limb muscle atrophy and Medical Research Council (MRC) score, handgrip strength, ICU Mobility Scale (IMS) score, and Functional Status Score for the ICU (FSS-ICU).Results: Sixty-four patients (43 males; aged 70 ± 13 years) were enrolled. The Acute Physiology and Chronic Health Evaluation (APACHE) II score was 27 (22–30), and in-hospital mortality occurred in 21 (33%) patients. The decreased cross-sectional area of the biceps brachii was not associated with in-hospital mortality on day 3 (p= 0.43) but was associated on days 5 (p= 0.01) and 7 (p< 0.01), which was confirmed after adjusting for sex, age, and APACHE II score. In 27 patients in whom physical functions were assessed, the decrease of the cross-sectional area of the biceps brachii was associated with MRC score (r= 0.47,p= 0.01), handgrip strength (r= 0.50,p= 0.01), and FSS-ICU (r= 0.56,p< 0.01), but not with IMS score (r= 0.35,p= 0.07) upon ICU discharge.Conclusions: Upper limb muscle atrophy was associated with in-hospital mortality and physical function impairments; thus, it is prudent to monitor it. (321 words)Trial registration: UMIN 000031316. Retrospectively registered on 15 February 2018.


  • Open Access

    Change in diaphragm and intercostal muscle thickness in mechanically ventilated patients: a prospective observational ultrasonography study

    by Nobuto Nakanishi, Jun Oto, Yoshitoyo Ueno, Emiko Nakataki, Taiga Itagaki, Masaji Nishimura

    Background: Diaphragm atrophy is observed in mechanically ventilated patients. However, the atrophy is not investigated in other respiratory muscles. Therefore, we conducted a two-center prospective observational study to evaluate changes in diaphragm and intercostal muscle thickness in mechanically ventilated patients. Methods: Consecutive adult patients who were expected to be mechanically ventilated longer than 48 h in the ICU were enrolled. Diaphragm and intercostal muscle thickness were measured on days 1, 3, 5, and 7 with ultrasonography. The primary outcome was the direction of change in muscle thickness, and the secondary outcomes were the relationship of changes in muscle thickness with patient characteristics. Results: Eighty patients (54 males and 26 females; mean age, 68 ± 14 years) were enrolled. Diaphragm muscle thickness decreased, increased, and remained unchanged in 50 (63%), 15 (19%), and 15 (19%) patients, respectively. Intercostal muscle thickness decreased, increased, and remained unchanged in 48 (60%), 15 (19%), and 17 (21%) patients, respectively. Decreased diaphragm or intercostal muscle thickness was associated with prolonged mechanical ventilation (median difference (MD), 3 days; 95% CI (confidence interval), 1–7 and MD, 3 days; 95% CI, 1–7, respectively) and length of ICU stay (MD, 3 days; 95% CI, 1–7 and MD, 3 days; 95% CI, 1–7, respectively) compared with the unchanged group. After adjusting for sex, age, and APACHE II score, they were still associated with prolonged mechanical ventilation (hazard ratio (HR), 4.19; 95% CI, 2.14–7.93 and HR, 2.87; 95% CI, 1.53–5.21, respectively) and length of ICU stay (HR, 3.44; 95% CI, 1.77–6.45 and HR, 2.58; 95% CI, 1.39–4.63, respectively) compared with the unchanged group. Conclusions: Decreased diaphragm and intercostal muscle thickness were frequently seen in patients under mechanical ventilation. They were associated with prolonged mechanical ventilation and length of ICU stay. Trial registration: UMIN000031316. Registered on 15 February 2018


  • High-Flow Nasal Cannula Oxygen Therapy Devices

    by Masaji Nishimura

    For hypoxemic respiratory failure, the frontline treatment is supplemental oxygen. Since ARDS was first described, mechanical ventilation via an endotracheal tube (invasive ventilation) has no doubt saved many patients. During the 1990s, noninvasive ventilation was found to be superior to invasive ventilation for exacerbations of COPD, acute cardiogenic pulmonary edema, and acute respiratory failure in patients who were immunocompromised. In the 2000s, less invasive high-flow nasal cannula (HFNC) therapy gained attention as an alternative means of respiratory support for patients who were critically ill. The HFNC system is simple: it requires only a flow generator, active heated humidifier, single heated circuit, and nasal cannula. While NIV interfaces add to anatomic dead space, HFNC delivery actually decreases dead space. Although the use of HFNC in adults who are critically ill has been dramatically increasing, the advantages and disadvantages of each element have not been well discussed. For now, although functional differences among the different HFNC systems seem to be minor, to avoid adverse clinical events, it is essential to know the advantages and disadvantages of each element.


  • Humidification in Very-High-Flow Nasal-Cannula Therapy in an Adult Lung Model

    by Yusuke Chikata, Keisuke Morinishi, Masaji Nishimura

    BACKGROUND: High-flow nasal cannula (HFNC) therapy is used for patients with respiratory failure. Recently, HFNC therapy with very high gas flows (ie, gas flows of 60–100 L/min) was reported to generate higher positive airway pressure and an associated decrease in breathing frequency. However, the humidification of HFNC therapy with very high gas flow remains to be clarified. METHODS: We evaluated 3 heated humidifier systems: a single MR850, the Hummax2, and parallel MR850s. The MR850 is a pass-over humidifier system, and the Hummax2 works with a porous hollow polyethylene fiber membrane. The parallel MR850 system included 2 MR850s connected in parallel to the lung with a 22 mm Y-piece. Gas flow was set at 40–90 L/min in increments of 10 L/min, and F IO 2 was set at 0.21. Heated humidifiers in the MR850 systems were set in invasive mode (40°C/−3), and with the Hummax2 the vapor temperature was set at 39°C. The simulated external nares were connected to a test lung via a standard ventilator circuit. One-way valves prevented mixing of inspired and expired gases. Compliance of the test lung was 0.05 L/cm H 2 O and resistance 5 cm H 2 O/L/s. Simulated tidal volumes (V T ) were 300, 500, and 700 mL, with a breathing frequency of 10 or 20 breaths/min and an inspiratory time of 1.0 s. Temperature, relative humidity, and absolute humidity (AH) of inspired gas downstream of the external nares were measured using a hygrometer for 1 min, and results for the last 3 breaths were extracted. RESULTS: With the single MR850, when gas flow was > 80 L/min, AH decreased as gas flow increased ( P < .001). With the Hummax2, as gas flow increased, AH decreased ( P < .001). With the parallel MR850s, regardless of gas flow, AH was constant. As breathing frequency increased, AH increased in all systems. CONCLUSIONS: During HFNC therapy with very high gas flows in this bench study, conventional heated humidifiers did not provide adequate humidification. Caution is advised when using HFNC therapy with very high gas flows with conventional heated humidifiers.


  • Bacterial Contamination of Circuit Inner Surfaces After High-Flow Oxygen Therapy

    by Mutsuo Onodera, Emiko Nakataki, Nobuto Nakanishi, Taiga Itagaki, Masami Sato, Jun Oto, Masaji Nishimura

    BACKGROUND: During high-flow oxygen therapy, heated humidified gas is delivered at high flow. Although the warmth and humidity of this gas facilitates mucociliary function in the lower airway, warm and humid conditions also promote bacterial growth. Bacterial contamination of high-flow oxygen therapy circuits has not been well investigated. We examined the incidence of bacterial contamination in high-flow oxygen therapy circuits. METHODS: This was a prospective observational study in a university hospital 10-bed general ICU. After final high-flow oxygen therapy discontinuation, samples were obtained from the interface and the chamber ends of the circuit. Initially, a half circumference of each inner surface was swabbed, after which the whole circuit was left in the ICU at room temperature for 6 h. The samples were then, in the same way, taken from the previously unswabbed arcs of the end inner surfaces. All the samples were sent to a biology laboratory and cultured. RESULTS: In all, 118 samples were collected from 31 circuits. The median duration of high-flow oxygen therapy was 48 h (interquartile range, 26–96 h). Of 31 circuits, contamination occurred in 5 circuits (16.1% [95% CI 5.5–33.7%]). CONCLUSIONS: Bacterial contamination of inner surfaces of the circuit after high-flow oxygen therapy was relatively high.


  • Influence of Nutritional Management and Rehabilitation on Physical Outcome in Japanese Intensive Care Unit Patients: A Multicenter Observational Study

    by Tomoaki Yatabe, Moritoki Egi, Masahiko Sakaguchi, Takashi Ito, Nobuhiro Inagaki, Hiromi Kato, Jun Kaminohara, Amane Konishi, Michiko Takahashi, Hiroomi Tatsumi, et al.

    Background: There is lack of evidence regarding nutritional management among intensive care unit (ICU) patients in a population with relatively low body mass index. Therefore, we conducted an observational study to assess the nutritional management in Japanese ICUs. Also, we investigated the impact of nutritional management and rehabilitation on physical outcome. Methods: The study population comprised 389 consecutive patients who received mechanical ventilation for at least 24 h and those admitted to the ICU for > 72 h in 13 hospitals. The primary outcomes were caloric and protein intake in ICU on days 3 and 7, and at ICU discharge. The secondary outcome was the impact of nutritional management and rehabilitation on physical status at ICU discharge. We defined good physical status as more than end sitting and poor physical status as bed rest and sitting. We divided the participants into 2 groups, namely, the good physical status group (Good group) and poor physical status group (Poor group) for analysis of the secondary outcome. Data were expressed as median (interquartile range). Results: The median amount of caloric intake on days 3 and 7, and at ICU discharge via enteral and parenteral routes were 8.4 (3.1–15.6), 14.9 (7.5–22.0), and 11.2 (2.5–19.1) kcal/kg/day, respectively. The median amount of protein intake on days 3 and 7, and at ICU discharge were 0.2 (0–0.5), 0.4 (0.1–0.8), and 0.3 (0–0.7) g/kg/day, respectively. The amount of caloric intake on day 3 in the Poor group was significantly higher than that of the Good group (10.1 [5.8, 16.2] vs. 5.2 [1.9, 12.4] kcal/kg/day, p < 0.001). The proportion of patients who were received rehabilitation in ICU in the Good group was significantly higher than that of the Poor group (92 vs. 63%, p < 0.001). The multivariate analysis revealed that caloric intake on day 3 and rehabilitation in ICU were considered independent factors that affect physical status (OR 1.19; 95% CI 1.05–1.34; p = 0.005 and OR 0.07; 95% CI 0.01–0.34; p = 0.001). Conclusions: The caloric and protein intakes in Japanese ICUs were 15 kcal/kg/day and 0.4 g/kg/day, respectively. In addition, critically ill patients might benefit from low caloric intake (less than 10 kcal/kg/day) until day 3 and rehabilitation during ICU stay.


  • Humidification Performance of Passive and Active Humidification Devices Within a Spontaneously Breathing Tracheostomized Cohort

    by Nobuto Nakanishi, Jun Oto, Taiga Itagaki, Emiko Nakataki, Mutsuo Onodera, Masaji Nishimura

    BACKGROUND: Most heat-and-moisture exchangers (HMEs) for patients with tracheostomy and spontaneously breathing are small and have suction ports that allow some expiratory gas to escape, which loses water vapor held in the expired gas. Recently, a heated-and-humidified high-flow system for spontaneously breathing patients with tracheostomy was developed. Little is known, however, about the humidifying performance of HMEs or heated-and-humidified high-flow systems for spontaneous breathing patients with a tracheostomy. OBJECTIVE: To investigate the humidifying performance of the HMEs and heated-and-humidified high-flow systems for spontaneously breathing patients with tracheostomy. METHODS: Adult spontaneously breathing subjects with tracheostomy and were enrolled when their respiratory parameters and S pO 2 were stable. We measured absolute humidity, relative humidity, and temperature by using a capacitance-type moisture sensor at the outlet of the tracheostomy tube. Heated-and-humidified high flow was delivered via the a humidifier and tracheostomy interface, and a selected HME. The subjects received heated-and-humidified high flow, after which an HME was used for humidification before switching back to a heated-and-humidified high-flow system. RESULTS: Ten subjects (5 men, 5 women; mean ± SD age, 72 ± 12 y) were enrolled. The admission diagnoses were neurologic (5 subjects), respiratory failure (3), and cardiac arrest (2). The APACHE (Acute Physiology and Chronic Health Evaluation) II score was 24 (interquartile range, 20–27). Tracheostomy was performed on day 7 (interquartile range, 5–11 d) after endotracheal intubation, and the duration of mechanical ventilation was 10 d (interquartile range, 6–11 d). The temperature with the HME was 29.9 ± 1.0°C and, during heated-and-humidified high-flow use was 35.3 ± 0.8°C ( P < .001). With both the HME and the heated-and-humidified high-flow system, the relative humidity reached 100%; the absolute humidity with HME was 30.2 ± 1.8 mg/L, and, with the heated-and-humidified high-flow system, was 40.3 ± 1.8 mg/L ( P < .001). CONCLUSIONS: In spontaneously breathing subjects with tracheostomy, an heated-and-humidified high-flow system achieved higher absolute humidity than did an HME.